Corient Capital Partners’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $347K | Buy |
7,970
+1,594
| +25% | +$69.4K | 0.03% | 422 |
|
|
2022
Q2 | $347K | Sell |
6,376
-666
| -9% | -$36.2K | 0.03% | 433 |
|
|
2022
Q1 | $383K | Buy |
7,042
+428
| +6% | +$23.3K | 0.03% | 451 |
|
|
2021
Q4 | $365K | Buy |
6,614
+1,984
| +43% | +$109K | 0.02% | 455 |
|
|
2021
Q3 | $221K | Buy |
+4,630
| New | +$221K | 0.02% | 605 |
|
|
2020
Q1 | – | Sell |
-4,708
| Closed | -$277K | – | 441 |
|
|
2019
Q4 | $277K | Buy |
4,708
+426
| +10% | +$25.1K | 0.04% | 374 |
|
|
2019
Q3 | $228K | Buy |
+4,282
| New | +$228K | 0.03% | 383 |
|